Clinical trial
Abatacept for the Treatment of Refractory Juvenile Dermatomyositis
NCT02594735 is registered in ClinicalTrials.gov with George Washington University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Abatacept for the Treatment of Refractory Juvenile Dermatomyositis
- Lead sponsor
- George Washington University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2015
- Completion date
- October 22, 2021
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.